Effects of Mind-body Exercises in a Patient With Mood Disorders: a Case Study.

Mood Disorders Clinical Trial

Official title:

Effects of Mind-body Exercises in a Patient With Mood Disorders: a Case Study.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05667844
• Other study ID #: IPUBCDA
• Status: Completed
• Phase: N/A
• Start date: March 1, 2022
• Est. completion date: August 15, 2022

Study information

• Verified date: December 2022
• Source: Universidade Federal do Rio de Janeiro
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The interoception capacity may be changed with mind-body intervention. This study case investigated the interoceptive capacity, measured by MAIA scale of a pacient with mood disorders and if it can be influenced through of a 7 weeks intervention of interoceptive exercises and the impaction in the patient´s daily life. The aim was analyse the effects of mind-body exercise program with interoceptive approach in the anxiety and depression symptoms, interoceptive capacity, as well your impact in paitient's daily activities. M.S is 47 years old, was forwarded from University Hospital Clementino Fraga Filho to extension project named as "corpo&mente" (body-mind), an anamnesis was performed including patient's life story, interoceptive scale, anxiety and depression scale from Hamilton and a risk stratification to realize physical activities (it was also performed post-intervention). The exercise program lasted 1h 15 min and it was performed once a week.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1
• Est. completion date: August 15, 2022
• Est. primary completion date: May 10, 2022
• Accepts healthy volunteers: No
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Participants with anxiety or/and depression clinical diagnosis

• Participants who do not do formal meditation practices

Exclusion Criteria:

• Participants with other diagnosis

• Patients with cognitive conditions

Related Conditions & MeSH terms

• Mind-body Exercise
• Mood Disorders

Intervention

Behavioral:
• interoceptive mind-body exercise
A interoceptive mind-body exercise program in a patient with Generalized Anxiety Disorder and Major Depressive Disorder based on a Multidimensional Assessment of Interoceptive Awareness. Each session of the body-mind intervention lasts 80 minutes and is supervised by physical education professionals. The intervention is divided in 4 parts, that are: Preparatory phase (reception) the subjects will be welcomed through subjective analyzes of the researcher; Initial phase (preliminares) Mindfulness, grounding, sensory stimulation and joint warm-up exercises are performed; main phase (exercises) stretching, mobility, posture and balance exercises are performed with full attention and listening after each exercise; Final phase (relaxation) breathing exercises, stretching exercises, body scanning and relaxation are performed.

Locations

Country	Name	City	State
Brazil	Federal University of Rio de Janeiro	Rio De Janeiro

Sponsors (1)

Lead Sponsor	Collaborator
Universidade Federal do Rio de Janeiro

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Mnteroceptive capacity	assessed by interoceptive scale named Multidimensional Assessment of Interoceptive Awareness. In this scale, the average of each of the seven dimensions is calculated, the higher the value, the greater the interoceptive capacity.	Day 1
Primary	Anxiety symptoms	To measure the level of anxiety symptoms the Hamilton Anxiety scale was performed. The Hamilton Anxiety Scale has 14 items, each item is scored from 0 (absent symptoms) to 4 (disabling symptoms(, The higher the scores, the greater the levels of anxiety.	Day 1 and after 7 weeks
Primary	Depression symptons	Hamilton Depression was used to measure the level of depression symptons. It has 21 items, where the scores for symptoms from 0 to 5. The higher the scores, the greater the levels of depression.	Day 1 and after 7 weeks